TABLE 1.
Clinical characteristics of UCEC patients.
| Characteristic | Low expression of CLDN6 | High expression of CLDN6 | p |
| n | 276 | 276 | |
| Clinical stage, n (%) | <0.001 | ||
| Stage I | 196 (35.5%) | 146 (26.4%) | |
| Stage II | 25 (4.5%) | 26 (4.7%) | |
| Stage III | 47 (8.5%) | 83 (15%) | |
| Stage IV | 8 (1.4%) | 21 (3.8%) | |
| Age, n (%) | <0.001 | ||
| ≤60 | 124 (22.6%) | 82 (14.9%) | |
| >60 | 150 (27.3%) | 193 (35.2%) | |
| Weight, n (%) | 0.036 | ||
| ≤80 | 109 (20.6%) | 134 (25.4%) | |
| >80 | 155 (29.4%) | 130 (24.6%) | |
| Histological type, n (%) | <0.001 | ||
| Endometrioid | 257 (46.6%) | 153 (27.7%) | |
| Mixed | 8 (1.4%) | 16 (2.9%) | |
| Serous | 11 (2%) | 107 (19.4%) | |
| Histologic grade, n (%) | <0.001 | ||
| G1 | 68 (12.6%) | 30 (5.5%) | |
| G2 | 83 (15.3%) | 37 (6.8%) | |
| G3 | 122 (22.6%) | 201 (37.2%) | |
| Menopause status, n (%) | 0.005 | ||
| Pre | 17 (3.4%) | 18 (3.6%) | |
| Peri | 15 (3%) | 2 (0.4%) | |
| Post | 217 (42.9%) | 237 (46.8%) |